Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07115173) titled 'Clinical Trial to Evaluate the Efficacy of Probit-Based Triple Therapy for Helicobacter Pylori Eradication' on Aug. 4.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Samsung Medical Center
Condition:
Helicobacter Infection
Intervention:
Drug: This study aims to evaluate the efficacy and safety of a 14-day triple therapy regimen consisting of Zastaprazan 20 mg, clarithromycin, and amoxicillin for the eradication of Helicobacter pylori.
Recruitment Status: Not recruiting
Phase: Phase...